High-Throughput Genomic Analysis in Waldenstrom's Macroglobulinemia

被引:19
作者
Poulain, Stephanie [2 ]
Braggio, Esteban [3 ]
Roumier, Christophe [1 ,4 ]
Aijjou, Rachid [2 ]
Broucqsault, Natacha [4 ]
Galiegue-Zouitina, Sylvie [4 ]
Manier, Salomon [1 ]
Soenen, Valerie [1 ,4 ]
Nibourel, Olivier [1 ,4 ]
Duthilleul, Patrick [2 ]
Fonseca, Rafael [3 ]
Leleu, Xavier [1 ,4 ]
机构
[1] CHRU, Serv Malad Sang, F-59037 Lille, France
[2] CH Valenciennes, UF Biol Mol, Valenciennes, France
[3] Mayo Clin, Scottsdale, AZ USA
[4] IRCL, Ctr Rech Inserm 837, Equipe 3, Lille, France
关键词
KAPPA-B PATHWAY; 6Q DELETION; MALIGNANCIES; MUTATIONS;
D O I
10.3816/CLML.2011.n.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Single-nucleotide polymorphism array (SNPa) and array-based comparative genomic hybridization (aCGH) are among the most sensitive genomic high-throughput screening techniques used in the exploration of genetic abnormalities in Waldenstrom's macroglobulinemia (WM). SNP and aCGH allow the identification of copy number abnormalities (CNA) at the kilobase level thus identifying cryptic genetic abnormalities unseen by lower-resolution approaches such as conventional cytogenetic or fluorescence in situ hybridization (FISH). CNA were identified in nearly 80% of cases by aCGH that delineated in addition minimal altered regions. At gene level, remarkable findings affecting genes involved in the regulation of the NF-kB signaling pathways were identified, such as biallelic inactivation of TNFAIP3 and TRAF3. SNPa also allowed characterization of copy neutral losses such as uniparental disomies (UPD), which is an important and frequent mechanism of gene alteration in cancer cells. Herein, we summarize the current knowledge of WM genomic basis using these high-throughput techniques.
引用
收藏
页码:106 / 108
页数:3
相关论文
共 18 条
[1]   Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenstrom's Macroglobulinemia [J].
Braggio, Esteban ;
Keats, Jonathan J. ;
Leleu, Xavier ;
Van Wier, Scott ;
Jimenez-Zepeda, Victor H. ;
Valdez, Riccardo ;
Schop, Roelandt F. J. ;
Price-Troska, Tammy ;
Henderson, Kimberly ;
Sacco, Antonio ;
Azab, Feda ;
Greipp, Philip ;
Gertz, Morie ;
Hayman, Suzanne ;
Rajkumar, S. Vincent ;
Carpten, John ;
Chesi, Marta ;
Barrett, Michael ;
Stewart, A. Keith ;
Dogan, Ahmet ;
Bergsagel, Leif ;
Ghobrial, Irene M. ;
Fonseca, Rafael .
CANCER RESEARCH, 2009, 69 (08) :3579-3588
[2]   Analysis of 6q deletion in Waldenstrom macroglobulinemia [J].
Chang, Hong ;
Qi, Xiaoying ;
Xu, Wei ;
Reader, Jocelyn C. ;
Ning, Yi .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (03) :244-247
[3]   TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs [J].
Hauer, J ;
Püschner, S ;
Ramakrishnan, P ;
Simon, U ;
Bongers, M ;
Federle, C ;
Engelmann, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (08) :2874-2879
[4]   TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas [J].
Honma, Keiichiro ;
Tsuzuki, Shinobu ;
Nakagawa, Masao ;
Tagawa, Hiroyuki ;
Nakamura, Shigeo ;
Morishima, Yasuo ;
Seto, Masao .
BLOOD, 2009, 114 (12) :2467-2475
[5]   Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma [J].
Keats, Jonathan J. ;
Fonseca, Rafael ;
Chesi, Marta ;
Schop, Roelandt ;
Baker, Angela ;
Ching, Wee-Joo ;
Van Wier, Scott ;
Tiedemann, Rodger ;
Shi, Chang-Xin ;
Sebag, Michael ;
Braggio, Esteban ;
Henry, Travis ;
Zhu, Yuan-Xiao ;
Fogle, Homer ;
Price-Troska, Tammy ;
Ahmann, Gregory ;
Mancini, Catherine ;
Brents, Leslie A. ;
Kumar, Shaji ;
Greipp, Philip ;
Dispenzieri, Angela ;
Bryant, Barb ;
Mulligan, George ;
Bruhn, Laurakay ;
Barrett, Michael ;
Valdez, Riccardo ;
Trent, Jeff ;
Stewart, A. Keith ;
Carpten, John ;
Bergsagel, P. Leif .
CANCER CELL, 2007, 12 (02) :131-144
[6]   Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies [J].
Maciejewski, Jaroslaw P. ;
Tiu, Ramon V. ;
O'Keefe, Christine .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (05) :479-488
[7]   Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies [J].
O'Keefe, Christine ;
McDevitt, Michael A. ;
Maciejewski, Jaroslaw P. .
BLOOD, 2010, 115 (14) :2731-2739
[8]   6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis [J].
Ocio, E. M. ;
Schop, R. F. J. ;
Gonzalez, B. ;
Van Wier, S. A. ;
Hernandez-Rivas, J. M. ;
Gutierrez, N. C. ;
Garcia-Sanz, R. ;
Moro, M. J. ;
Aguilera, C. ;
Hernandez, J. ;
Xu, R. ;
Greipp, P. R. ;
Dispenzieri, A. ;
Jalal, S. M. ;
Lacy, M. Q. ;
Gonzalez-Paz, N. ;
Gertz, M. A. ;
San Miguel, J. F. ;
Fonseca, R. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (01) :80-86
[9]   Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia [J].
Owen, RG ;
Treon, SP ;
Al-Katib, A ;
Fonseca, R ;
Greipp, PR ;
McMaster, ML ;
Morra, E ;
Pangalis, GA ;
Miguel, JFS ;
Branagan, AR ;
Dimopoulos, MA .
SEMINARS IN ONCOLOGY, 2003, 30 (02) :110-115
[10]  
POULAIN S, 2010, BLOOD